Benefit vs potential harm of genome-wide prenatal cfDNA testing requires further investigation and should not be dismissed based on current data

Bekker, M. N.; Henneman, L.; Macville, M. V.E.; Sistermans, E. A.; Galjaard, R. J.H.

doi:https://doi.org/10.1002/uog.22030

Benefit vs potential harm of genome-wide prenatal cfDNA testing requires further investigation and should not be dismissed based on current data

DSpace/Manakin Repository

Benefit vs potential harm of genome-wide prenatal cfDNA testing requires further investigation and should not be dismissed based on current data

Bekker, M. N.; Henneman, L.; Macville, M. V.E.; Sistermans, E. A.; Galjaard, R. J.H.

(2020) Ultrasound in Obstetrics and Gynecology, volume 55, issue 5, pp. 695 - 696

(Letter)

Download/Full Text

The full text of this publication is not available.

Version on publisher website for UU-students and staff

Version on publisher website

Keywords: Radiological and Ultrasound Technology, Reproductive Medicine, Radiology Nuclear Medicine and imaging, Obstetrics and Gynaecology

DOI: https://doi.org/10.1002/uog.22030

ISSN: 0960-7692

Publisher: John Wiley and Sons Ltd

Note: Funding Information: All authors are affiliated with the Dutch NIPT Consortium that initiated the TRIDENT studies in The Netherlands. The TRIDENT studies are supported by a grant from The Netherlands Organization for Health Research and Development (ZonMw, No. 543002001).

(Peer reviewed)